Tom Malone Email & Phone Number

Leverkusen, North Rhine-Westphalia, DE

Lead customer engagement strategies, manage Payer customer relationships and deliver profitable access, reimbursement, and appropriate policy for Bayer brands at assigned accounts (Ex. Horizon BCBS-NJ, Independence BC, Empire BCBS, Affinity Health, Fidelis, etc.) Collaborate, coordinate, and align with internal stakeholders to improve patient access to.

• Established a successful consulting-advisor agency, providing expert market access landscape and strategy advice to Pharma, Biotech, Investment Bankers, Life Science Consulting, and Research firms for improved.
• Secured partnership with a mid-sized pharmaceutical company on how to approach the payer community with Pre-Approval Information Exchange 18 months before a new product launch; designed a program that ultimately drove.
• Delivered an improved approach for a HUB Services provider for a Bio-Pharmaceutical response - RFP strategy that resulted in immediate incremental business success for the client
• Partnered with a creative marketing firm as a Subject Matter Expert to bolster Bio-Pharmaceutical Market Access, Communications, Payer Strategy, and Patient Support Capabilities.

Whippany, NJ, US

• Promoting the full line of ConnectiveRx Patient Support Services (Hub, Copay, Affordability, and EHR Messaging Services) to existing and prospective BioPharma clients. Improving affordability, accelerating speed to.
• Responsible for ~$22M in annual revenue (2023), representing a 64% YoY growth with new and existing business
• Leading revenue growth by selling patient support services, achieving 210% of the quota
• Recipient of Signature Award – Hubc Patient Support Services (2021)

Malvern, PA, US

• Directed the National Account Executive Team, focusing on commercial managed health care, Medicare, Medicaid, and federal channels. Represented the entire Endo portfolio, prioritizing the Pain and Specialty product.
• Delivered 90.2% favorable commercial access for Belbuca nine months post-launch, igniting prescription volume and market share growth
• Orchestrated orderly exit from the payer market for OPANA ER after voluntary market withdrawal, with no negative impacts on continuing patients
• Refreshed Xiaflex Payer Value Proposition, targeting Payers & IDNs, improving placement in the treatment algorithm
• Decreased Xiaflex’s unfavorable medical policy status, immediately improving demand fulfillment
• Contributed to the design and launch of the harmonized Xiaflex Access & Reimbursement Support Program: Merged two programs previously separated by indication (Peyronie’s Disease and Dupuytren’s Contracture) into a.

Princeton, NJ, US

• Led culture transformation with the mindset adoption that the dignity of every human being matters in establishing a path to treatment. Guided development and execution of numerous patient support programs.
• Devised, proposed, and launched the ASSURE Program, which expanded several disparate functions to create a company capability with a mission to clear a path to treatment after a clinical decision to prescribe
• Responsible for a $4M agency and vendor spend, and oversaw hiring, training, performance, and development of an 86-person group that included Operations, Strategy, Messaging, and Field Support personnel
• Increased Q1 post-launch customer outreach to the ASSURE Support Line by >100%
• Recipient of Presidential Award for Leadership Otsuka America Pharmaceuticals (2014)

Princeton, NJ, US

• Built the Market Access Marketing department at OAPI, building staff, brand payer strategy, payer support materials, approval, deployment, and training to support the commercial launch of Abilify Maintena and.
• Achieved launch year Abilify Maintena commercial and Medicare formulary access objectives of matching the competitive market leader within eight months, opening pathways for clinicians to prescribe drug uninhibited by.
• Developed and deployed the Abilify Maintena TreatNOW Starter program, the first HCP self-service patient starter program in the Atypical Anti-Psychotic market; the initiative delivered a year-one +$15M net revenue impact
• Influenced organization to adopt and utilize FDAMA 114 materials through Account Executives for the first time, co-developed related SOPs, standardized vocabulary, principles, and metrics for the new Otsuka organization
• Recipient of OAPI Jissho-Shugi Award - Demonstrating Capabilities Beyond One’s Role, issued by Otsuka (2013)

US

• Directed strategic planning, development, and training of sales teams, coaching directors, and leading marketing design.
• Created marketing strategy for Hospital Administrator target market to progress product adoption as a complement to existing provider-focused approach

Rosemont, IL, US

• Directed strategic marketing and planning, integrating pharmaceutical sales and marketing initiatives. Led sales team management coaching and successful sales advancement programs for promising top talent.
• Created and installed a streamlined approach to sales planning and coaching that became the SOP for a Top 10 Pharmaceutical Sales Management Team (Midwest, US)

Cambridge, Cambridgeshire, GB

• Revised and implemented the CRESTOR Managed Markets brand strategy, identifying market opportunities and developing tactical plans to optimize investment in Managed Care Contracting through sales pull-through and.
• Responsible for a $1B brand rebate budget and sparked incremental revenue on brand market growth by $90M
• Improved Formulary Access from 52% to 78% (best-in-class)
• Evolved HCP messaging to leverage best-in-class formulary position
• Initiated a Copay e-voucher program, the first of its kind at AstraZeneca, delivering a 5:1 ROI in the first year
• Created regionalized pull-through campaigns to leverage competitive formulary advantages

Cambridge, Cambridgeshire, GB

Accountable for the successful development of Managed Markets Brand Strategy for CRESTOR. Responsible for identifying market opportunities and developing tactical plans to optimize the brand investment in Managed Care Contracting.Significantly improved the Prescriber Perception of CRESTOR Formulary access in 2009 to be 'On Par' with market leader through a.

Cambridge, Cambridgeshire, GB

Accountable for the successful implementation of the CRESTOR Managed Markets Brand Strategy in the Commercial Payor environment; provided direction for a $700,000,000+ rebate budget. Responsible for the contract approval process, business case development and negotiations for national and key regional accounts. Primary access point for Account Directors.

Cambridge, Cambridgeshire, GB

Created, developed and executed several initiatives that measured and improved the effectiveness of the AstraZeneca primary sales team. Including Success-based Hiring Criteria; Territory Prioritization and Vacancy Management; Information Systems Tools Enhancement Criteria Setting; New Selling Model Workstream Owner

Cambridge, Cambridgeshire, GB

Headquarters position - Worked for the National Sales Director and Commercial Brand Leader as liason for Sales and Marketing integration during the 1st 10 months of CRESTOR launch. Involved in all day to day decision making support and field communications. Delivered regular presentations to Sales and Marketing about the priorities and challenges faced.

Cambridge, Cambridgeshire, GB

Progressed to positions of increasing responsibility in the Sales organization, including: Primary Care Sales Representative; Hospital Sales Representative, District Manager, Regional Sales Director.